Calcium-channel blockers and risk of cancer [9]

Lancet

Volumn 349, Issue 9062, 1997, Pages 1400-

  Kritchevsky, S B ^a   Pahor, M ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; VERAPAMIL;

CANCER; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; DRUG MEGADOSE; HUMAN; LETTER; PRIORITY JOURNAL;

EID: 0031003740     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)63246-1     Document Type: Letter

References (5)

1. H Jick S Jick LE Derby C Vasilakis MW Myers CR Meier Calcium-channel blockers and risk of cancer Lancet 349 1997 525 528
2. M Pahor JM Guralnik L Ferrucci Calcium channel blockade and incidence of cancer in aged populations Lancet 348 1996 493 497
3. L Hardell M Fredrikson O Axelson Case-control study in colon cancer regarding previous diseases and drug intake Int J Oncol 8 1996 439 444
4. E Negri C La Vecchia A Nobili B D'Avanzo S Bechi Cigarette smoking and acute myocardial infarction: a case-control study from the GISSI-2 trial Eur J Epidemiol 10 1994 361 366
5. JR Daling Calcium channel blockers and cancer: is an association biologically plausible? Am J Hypertens 9 1996 713 714